Capital expenditure · 2023–2025
Genmab capital expenditure
$37.0M+37.0% · FY2025
Genmab (GMAB) reported $37.0M in capital expenditure for fiscal 2025, +37.0% year on year.
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2023–2025 compound annual growth −16.4%
Figures are reported under IFRS, in US dollars.
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Genmab capital expenditure |url=https://companiesranked.com/en/company/genmab/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Genmab capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/genmab/capital-expenditureBibTeX
@misc{companiesranked-en-company-genmab-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Genmab capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/genmab/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001434265-26-000014 · February 17, 2026
{{cite web |title=Genmab capital expenditure — 20-F (0001434265-26-000014) |url=https://www.sec.gov/Archives/edgar/data/1434265/000143426526000014/gmab-20251231_d2.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-17}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.